Revvity Inc vs Vanguard Information Technology Index Fund ETF — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while Vanguard Information Technology Index Fund ETF trades at $127.98 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 10× Revvity Inc's market cap, and Revvity Inc pays a 0.18% dividend while Vanguard Information Technology Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Vanguard Information Technology Index Fund ETF for 129 Days on average.
| RVTY | VGT | |
|---|---|---|
Market Cap | $16.98B | $170.20B |
Volume | 1,456,900 | 5,132,883 |
Sector | Health | — |
52-Week High | $157.36 | $129.79 |
52-Week Low | $82.26 | $83.59 |
Typical Hold Time | 12 Days | 129 Days |
Enterprise Value | $19.30B | — |
Dividend Yield | 0.18% | — |
Signals from Pluang's Aura AI — not financial advice
Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.
The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.
VGT trades at $127.98, down 1.07% on the day, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights its strong historical performance and appeal for long-term growth, with a focus on technology sector exposure. The ETF's low expense ratio and concentration in top tech names like Nvidia, Apple, and Microsoft are key attractions.
Outlook remains positive given tech sector momentum, but risks include high concentration in a few stocks and sensitivity to AI growth trends. Dividend yield is minimal, emphasizing capital appreciation over income. Investors should weigh sector volatility against long-term growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →